GLYCERIN,ANHYDROUS
Colorectal Cancer
European Institute of OncologySmall moleculeN/ADormant
D
26/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 59/ 100
Competitive context
482 Active assets in the Colorectal Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Calcium folinate pentahydrate UNICANCER | Phase 4 | BB |
PANITUMUMAB MSPU des 3 Provinces | Phase 3 | BB |
Levoleucovorin Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Phase 3 | BB |
FLUOROURACILUM UNICANCER | Phase 4 | BB |
Eloxatin Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Phase 4 | BB |
View all 50 →
Same molecule, other indications
GLYCERIN,ANHYDROUS is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →